Finance

Lists
1276:HKG
Jiangsu Hengrui Pharmaceuticals Co Ltd
47,60 HK$
-0,83%
(-0,40) 1D
16 հոկ, 16:08:14 GMT+8  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 1276...
Open
48,00 HK$
High
49,30 HK$
Low
46,92 HK$
Mkt. cap
345,69 մլրդ
Avg. vol.
4,04 մլն
Volume
4,16 մլն
P/E ratio
34,86
52-wk high
84,50 HK$
52-wk low
43,02 HK$
EPS
1,37 HK$
No. of employees
21 հզր
Open
48,00 HK$
High
49,30 HK$
Low
46,92 HK$
Mkt. cap
345,69 մլրդ
Avg. vol.
4,04 մլն
Volume
4,16 մլն
P/E ratio
34,86
52-wk high
84,50 HK$
52-wk low
43,02 HK$
EPS
1,37 HK$
No. of employees
21 հզր
News stories
From web sources and news partners
Profile
Jiangsu Hengrui Pharmaceuticals Company Ltd., also known as Jiangsu Hengrui, is a Chinese pharmaceutical company that manufactures and distributes various types of drug packaging materials, cancer-treating antineoplastics, cardiovascular medication, painkillers, antibiotics, and related products. It is the largest listed pharmaceutical company in China. Wikipedia
About Jiangsu Hengrui Pharmaceuticals Co Ltd
CEO-
Employees20,7 հզր
Founded1970
Headquarters-
Sector-
Next call 8 օրից
հոկ 27, երք, 09:00
Fiscal period
Q3 2026
- / 0,31 CN¥
Revenue / Est. (CNY)
- / 9,17 մլրդ
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
7,43 մլրդ
8,44 մլրդ
8,14 մլրդ
7,32 մլրդ
Cost of goods sold
1,07 մլրդ
1,25 մլրդ
1,09 մլրդ
1,02 մլրդ
Cost of revenue
1,07 մլրդ
1,25 մլրդ
1,09 մլրդ
1,02 մլրդ
Research and development expenses
1,72 մլրդ
2,02 մլրդ
1,65 մլրդ
1,84 մլրդ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3,23 մլրդ
3,01 մլրդ
2,81 մլրդ
2,78 մլրդ
Operating expense
4,76 մլրդ
5,35 մլրդ
4,48 մլրդ
4,61 մլրդ
Total operating expenses
5,83 մլրդ
6,60 մլրդ
5,57 մլրդ
5,63 մլրդ
Operating income
1,60 մլրդ
1,84 մլրդ
2,57 մլրդ
1,68 մլրդ
Other non operating income
-154,21 մլն
145,74 մլն
-345,12 մլն
243,91 մլն
EBT including unusual items
1,36 մլրդ
2,30 մլրդ
2,56 մլրդ
2,40 մլրդ
EBT excluding unusual items
1,68 մլրդ
1,91 մլրդ
2,55 մլրդ
1,60 մլրդ
Income tax expense
55,51 մլն
338,85 մլն
275,87 մլն
211,27 մլն
Effective tax rate
4,08%
14,76%
10,79%
8,82%
Other operating expenses
-217,30 մլն
326,84 մլն
4,76 մլն
-5,09 մլն
Net income
1,30 մլրդ
1,96 մլրդ
2,28 մլրդ
2,18 մլրդ
Net profit margin
17,52%
23,22%
28,04%
29,84%
Earnings per share
0,20
-
-
-
Interest and investment income
242,14 մլն
288,66 մլն
322,96 մլն
448,28 հզր
Interest expense
-689,68 հզր
-2,00 մլն
-448,28 հզր
-322,96 մլն
Net interest expenses
241,45 մլն
286,66 մլն
322,52 մլն
-322,52 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
1,78 մլրդ
2,04 մլրդ
2,77 մլրդ
1,93 մլրդ
Gain or loss from assets sale
2,31 մլն
-4,05 մլն
-
-40,62 մլն
AI content may include mistakes. Learn more
Google Apps